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ABSTRACT
Examination of Anabolic Signaling and Muscle Growth with Caffeine
Treatment in Overloaded Hindlimb Muscle and Electrically
Stimulated Muscle Lacking Liver Kinase B1
Timothy Michael Moore
Department of Physiology and Developmental Biology, BYU
Master of Science
Skeletal muscle has the ability to increase in size (hypertrophy) after resistance is placed
upon it. This hypertrophy is marked by significant upregulation of the mammalian target of
rapamycin (mTOR) and its downstream targets. The upstream kinases, protein kinase B (also
known as Akt) and AMP-activated protein kinase (AMPK), are two of the many regulators of the
mTOR pathway. Recent studies suggest that the widely consumed neuroactive compound
caffeine could potentially inhibit mTOR by acting through Akt and/or AMPK. The purpose of
this thesis was to: 1) determine if caffeine can inhibit the mTOR pathway and ultimately
attenuate skeletal muscle hypertrophy and 2) determine if this inhibition is through LKB1, an
upstream regulator of AMPK.
First, 3 month old male rats underwent unilateral tenotomy of the gastrocnemius,
resulting in overloading (OVLD) of the synergistic plantaris muscle. The contralateral limb was
sham-operated (SHAM) on. Rats were given ad libitum access to tap water or tap water +
caffeine (1 g/L). The OVLD procedure resulted in significant hypertrophy of the plantaris which
was attenuated after 1 wk of caffeine treatment. However, after two wks this effect was not
observed. mTOR targets were examined in both the SHAM and OVLD plantaris muscle which
showed significant upregulation with OVLD but no impact with caffeine treatment. Akt and
AMPK was also assessed in the plantaris muscle which showed diminished Akt phosphorylation
in 1 wk treated rats while the phosphorylation of AMPK remained relatively unaffected.
Notably, caffeine caused decreased atrophy of the tenotomized gastrocnemius after 1 wk along
with decreased body weight gains, food consumption, and retroperitoneal fat pad weight in both
1 and 2 wk treated rats.
Sec, to elucidate how caffeine could be impacting the mTOR pathway and how
LKB1/AMPK might be involved, skeletal muscle specific LKB1 knockout (skmLKB1-KO) mice
were subjected to high-frequency electrical stimulation (HFES) of the sciatic nerve resulting in
contraction of the tibialis anterior (TA) and extensor digitorum longus (EDL) muscles against the
larger gastrocnemius. All mice were given an intraperitoneal injection of saline or saline +
caffeine (20 mg/kg BW at 1 g/L). HFES resulted in marked upregulation of mTOR targets in the
TA/EDL of mice 0, 3, and 8 h post HFES. mTOR targets remained relatively unchanged with
caffeine treatment. We also observed that these markers were consistently upregulated in our
skmLKB1-KO mice with or without HFES. Our findings indicate that caffeine, at physiological
concentrations, does not impact anabolic signaling. Furthermore, diminished LKB1 levels
resulted in increased levels and activation of markers of protein synthesis.
Key Words: mTOR, hypertrophy, caffeine, AMPK, LKB1
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CHAPTER 1: Literature Review
Skeletal Muscle: A Brief Overview
Skeletal muscle is one of the three major muscle types in mammalian organisms. This
mesoderm derived striated tissue accounts for 30-40% of total body mass and permits the
contractile activity necessary to sustain movement [Janssen, 2000]. A muscle comprises all
tissue ensheathed by the outer most layer of connective tissue called the epimysium. This
includes all blood vessels, muscle tissue, connective tissue, lymphatics, and resident immune
cells naming only the more abundant types. Skeletal muscle tissue is further divided into long
strands of fibers encompassed by a sheath of connective tissue called the perimysium. Several
myocytes, also known as myofibers, fill the perimysium running parallel to one another and are
one of the few cell types that are multinucleated within mammalian organisms. Such cells form
from the fusion of several myoblasts, a process that occurs during both embryonic development
and adult life. Each myofiber is further ensheathed by an additional layer referred to as the basal
lamina. The striated nature of myofibers is due to the repetition of sarcomeres [Scott, 2001].
Sarcomeres are considered the functional unit of skeletal muscle and are composed of
overlapping myosin and actin filaments that interact in such a way as to allow for contraction and
subsequent movement. See Figure 1.1 for a simplified cross section of a skeletal representation.
Skeletal Muscle Hypertrophy
Skeletal muscle cells have the ability to grow (hypertrophy) after increased loading. Not
only is skeletal muscle able to hypertrophy (change its mass/volume ratio), it can also alter the
particular myosin isoform expressed. This transforms the muscle fiber into an adapted fiber type
better able to meet its demands. Hypertrophy in response to training is marked by an overall
increase in the size of the skeletal muscle fibers instead of amplification of fiber number [Glass,
1

2010]. For fibers to undergo hypertrophy, the rate of protein synthesis must be greater than the
rate of protein degradation. Thus, there is an essential role for protein synthesis pathways and
related pathways that either promote the formation of proteins or impede their degradation.
Protein synthesis is pivotally dependent upon a number of key pathways resulting in
myofibrillar protein accumulation and subsequent skeletal muscle hypertrophy. The mammalian
target of rapamycin (mTOR) pathway has been shown to be a regulator of the increase in muscle
size that results from mechanical stimulation (increased loading upon the muscle) [Bodine,
2001]. Work in S. cerevisiae has shown that the timing and location of growth are both
dependent upon this pathway [Wullschleger, 2006]. Furthermore, in the rat, blocking mTOR
prevents muscle growth during development and under overload (OVLD) conditions [Bodine,
2001; Bodine, 2006; Reynolds, 2002].
Upstream of mTOR is Akt, also known as protein kinase B. Work utilizing Akt knockout
mice results in a myriad of conditions ranging from diabetes, neural tube defects, and growth
deficiency showing the versatility this molecule has within various cell types [Yang, 2004].
Phosphorylation of Akt through interaction with phosphatidylinositol 3 kinase (PI3K) results in
downstream activation of mTOR [Krakstad, 2010]. Refer to Figure 1.2 for a simplified
representation of the mTOR pathway.
Activation of the PI3K/Akt/mTOR pathway seems to be able to happen in immediate and
later fashions after muscle stimulation. The later activation can happen through a number of
factors, either autocrine or paracrine in nature, including various nutrients such as amino acids or
muscle growth factor (MGFs) such as insulin-like growth factor-1 (IGF-1) [Rennie, 2003;
Hornberger, 2006]. The immediate response is believed to originate from the mechanical stimuli
[Reynolds, 2002]. This contraction based activation results in phosphorylation of a different
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serine residue, Ser2035 than the traditional IGF-1 based activation site on mTOR, Ser2448.
Nevertheless, hypertrophy is still a result and activation of a number of the same effector
pathways occurs [Reynolds, 2002].
Activation of mTOR increases protein synthesis by subsequent phosphorylation of the
serine/threonine kinase p70S6 (S6k) which further targets and phosphorylates the S6 ribosomal
protein (S6) [Baar, 1999]. mTOR has additional targets including eukaryotic translation
initiation factor 4E-binding protein 1 (4EBP1) that also aides translation [Kubica, 2005]. mTOR
and its effectors are essential for a hypertrophic response as a result of increased muscle loading
[Reynolds, 2002].
The robust activation of the mTOR pathway through a mechanical stimulus can be
accomplished experimentally in rodents by a number of different methods. Each method
typically falls into one of the following categories: exercise training, electrical stimulation, or
compensatory overload.
Exercise training can be either aerobic or anaerobic. Both protocols can induce skeletal
muscle hypertrophy although aerobic training protocols have difficulty inducing substantial
muscle hypertrophy. Anaerobic training protocols in rodent have been used for decades and
resemble weight bearing exercises in humans. However, rodents do not train well often needing
an external stimulus such as food or an electrical shock. Such stimuli can be seen as forced
exercise inducing a high amount of stress upon the animal. An additional drawback is the
amount of time needed to gain significant results. Some studies report 10-30% increases in
muscle cross sectional area (CSA) requiring anywhere from 8 – 36 wks of training [Ho, 1980;
Fluckey, 1995; Lowe, 2002]. Increasing CSA size over 30% is strenuous on the animals and
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burdensome on researchers due to time constraints with more realistic growth rates ranging from
10-15% over a few months.
High frequency electrical stimulation of the sciatic nerve (HFES) has been shown to
activate mTOR targets, namely S6K and 4EBP1, [Thomson, 2008] and result in skeletal muscle
hypertrophy of the tibialis anterior (TA) and extensor digitorum longus (EDL) muscles [Baar
1999]. In addition, this model allows direct comparisons between resting and stimulated muscles
within the same animal. Other advantages includes: independence from the animal’s motivation,
stimulation of any muscle desired, and large control over the type of stimulation including
duration, frequency, or intensity. Such control can allow for a wide range of studies to be
employed. Nevertheless, surgery, however minor or careful, is needed and results in some
amount of injury and inflammation to the animal. Furthermore, these animals must repeatedly
undergo anesthesia and care to prevent further injury to the wound if they are to undergo
repeated bouts.
Compensatory overload (OVLD) of a muscle occurs when its synergists are rendered
unable to function. OVLD experiments have repeatedly been used to induce skeletal muscle
hypertrophy [Adams, 1996; Armstrong, 1979]. One of three different protocols can be used:
tenotomy of synergist, synergist ablation, or synergist denervation. A tenotomy refers to
severing the tendon of a muscle rendering it unable to function. This procedure can result in a 40
and 20% increase in the mass of the soleus and plantaris muscles respectively when performed
on the tendon of the gastrocnemius muscle after 14 d [Goldberg, 1967]. Synergist ablation
involves at least partial removal of a muscle along with the tendon and also induces significant
hypertrophy. In female rats whose gastrocnemius and soleus muscles had been partially excised,
the plantaris grew 65% over a 9-wk period [Baldwin, 1982]. The final OVLD experiment
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involves synergistic denervation where nerve branches to specific muscles are severed. One
study showed that when the gastrocnemius and soleus muscles of rodents were denervated, the
plantaris muscle grew 30-40% in 3 wks [Degens, 1995]. Taken together, the main advantage of
these techniques is the large scale hypertrophy that occurs. Drawbacks include the higher levels
of initial inflammation within the first few days immediately following the surgery and the direct
applicability to a human condition.
AMPK and its link to mTOR
5’ adenosine monophosphate-activated protein kinase (AMPK) is a highly conserved
metabolic sensor expressed in a wide range of eukaryotes including yeast and humans as well as
a variety of tissues including hepatocytes, myocytes, and neurons [Steinberg, 2009]. AMPK
forms a heterotrimeric complex combining various isoforms of alpha, beta, and gamma subunits.
The beta and gamma subunits are regulatory in function while the alpha acts as the catalytic
domain [Winder, 1999]. AMPK becomes activated by interaction with liver kinase B1 (LKB1)
complexed with STE-related adaptor alpha (STRADα) and mouse protein 25 alpha (MO25α)
[Hawley, 2003; Suter, 2006; Smith, 2011]. LKB1is typically nuclear bound and must complex
with STRADα and MO25α before it is exported to the cytosol [Dorfman, 2008]. As metabolic
activity increases within a cell and the ratio of AMP:ATP begins to increase, AMPK becomes
activated. Two AMPs bind to the gamma subunit causing a conformational change that exposes
Threonine 172 within the alpha subunit [Adams, 2004]. The complex of
LKB1:STRADα:MO25α is then able to phosphorylate AMPK at Thr 172 allowing it to activate
catabolic, ATP producing, processes and to inhibit anabolic, ATP consuming, processes
[Shackelford, 2009].
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AMPKs inhibition of anabolic processes extends to the inhibition of the mTOR pathway
in skeletal muscle [Bolster 2002; Thomson, 2008]. This inhibition is believed to attenuate
protein synthesis and ultimately diminish muscle growth [Mounier, 2011]. AMPK can deter the
mTOR pathway in a few ways such as: phosphorylation of tuberous sclerosis complex 2 (TSC2)
an upstream regulator of mTOR [Inoki, 2003; Corradetti, 2004], or phosphorylation of raptor, a
member of the mTOR complex that is essential for mTOR activity [Gwinn, 2008].
As mentioned previously, the alpha subunit of the heterotrimeric complex that comprises
AMPK is responsible for the catalytic activity [Winder, 1999]. Two distinct isoforms of the
alpha subunit exist, namely alpha1 (α1) and alpha2 (α2), with the α1 subunit appearing to be
more integrated in regulating protein synthesis and muscle growth [Mounier, 2009]. This work
was conducted using an OVLD model to induce skeletal muscle hypertrophy of the plantaris in
AMPKα1 -/- mice. The findings by Mounier et al showed that mTOR activity was significantly
upregulated in the AMPKα1 -/- mice via increased phosphorylation of S6K, S6, and 4EBP1.
McGee et al conducted similar research utilizing a plantaris OVLD model within an LKB1-KO
mouse specifically in striated muscle, testis, kidney, and lung. This LKB1-KO mouse showed
trace amounts of α2 activity and a 60% reduction in α1 activity in control plantaris muscles when
compared to their wild type littermates. Despite the reduction in α1 activity in both control and
OVLD muscles, McGee et al further reported that LKB1-KO did not impact the phosphorylation
of S6K, S6, or 4EBP1 in response to OVLD [McGee, 2008]. To further complicate matters,
Mounier et al later showed that the diameter of myotubes isolated from AMPKα2-deficient mice
were 25% smaller than control myotubes and that their ability to respond to a hypertrophic
stimuli was impaired [Mounier, 2011]. It is clear that more experiments are needed to know how
exclusively each alpha subunit functions with regards to mTOR activation.
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Caffeine
Caffeine is arguably the most consumed drug today. It is found in a variety of products
with a wide range of physiological and psychological effects. The health effects of caffeine can
be positive including a temporary increase in attention, alertness, and metabolic rate while the
side effects consist of anxiety, addiction, tolerance, increased blood pressure, and increased
urination [Winston, 2005]. Caffeine can also impact cellular processes such as the cell cycle,
apoptosis, increased calcium release from the sarcoplasmic reticulum within skeletal muscles,
and enhanced central nervous system activity [Bode, 2007; Warren, 2010]. For reference, it is
estimated that the average consumption of caffeine in the United States is about 2 cups of coffee
(~150-250 mg) with 10% of the population ingesting over 1000 mg/d [Graham, 2001].
Caffeine is believed to have an ergogenic effect upon endurance exercise although the
mechanisms are varied and complex [Graham, 2001, Warren, 2010; Gliottoni 2009].
Specifically, caffeine has been found to block adenosine receptors within tissues. Such receptors
are found in most tissues including the brain, three different muscle types, and adipocytes. Due
to this fact, the impact of caffeine upon the body can be the culmination of several specific tissue
responses. At concentrations that are physiologically relevant to humans, caffeine has a
pronounced effect upon the central nervous system as well as other brain centers and thus
impacts various behavioral characteristics including learning, memory, performance,
coordination, arousal, vigilance, and fatigue to name some of the more studied ones [Graham,
2001; Nehlig, 1992].
Because of these side effects, caffeine is widely used among the general population but
recent literature might point to a negative impact upon skeletal muscle. Caffeine treatment at
mM concentrations has been shown to block the activity of Akt and subsequently inhibit mTOR
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potentially attenuating protein synthesis [Kolnes, 2010; Egawa, 2011]. Furthermore, in vitro
studies involving incubation with caffeine also show increased activation of AMPK in rat
epitrochlearis and soleus muscles [Lally, 2012]. In addition, Egawa et al found that caffeine
activated both AMPK subunits at 3 mM, but Abbott et al reported that caffeine increased
AMPKα2 activity only at a similar concentration [Abbott, 2009]. McConell et al further found
that at 5 mM, caffeine did not increase pAMPK in L6 myotubes [McConell, 2010].
Nevertheless, such levels are supraphysiological as 2 – 5 cups of coffee can result in blood
concentrations in the 15 – 80 μM range depending upon the individual [Birkett, 1991].
Therefore, it is not yet known whether caffeine at physiological concentrations has an impact
upon skeletal muscle anabolic signaling and hypertrophy.
Specific Aims
To summarize, skeletal muscle is able to respond to increased loading by increasing
muscle fiber size. This hypertrophy is dependent upon the mTOR signaling pathway. mTOR is
regulated by a number of different pathways and compounds one of which is LKB1/AMPK,
although the interaction is complex and varied. Caffeine is also believed to impair mTOR
signaling by inhibiting Akt, an upstream molecule involved in its activation. However, the effect
of chronic caffeine treatment upon skeletal muscle growth is unknown although literature
searches suggest a potential deleterious effect upon hypertrophy.
Specific Aim #1: Determine How Oral Caffeine Administration Affects Skeletal Muscle
Hypertrophy and mTOR Signaling in Overloaded Rat Muscle.
Three month old rats were given tap water or tap + water plus caffeine (1 g/L) after
which unilateral tenotomy of the gastrocnemius and soleus muscles to induce hypertrophy of the
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plantaris was commenced. I hypothesized that caffeine treated animals would have decreased
hypertrophy of the tenotomized limb at both time points.
Specific Aim #2: Determine the Role of LKB1 with Regards to Caffeine’s Impairment of mTOR
Activation after an Individual Bout of Resisted Muscle Contractions.
Three month old conditional or skeletal muscle specific LKB1 KO mice were given an
intraperitoneal injection of saline or saline + caffeine after which high-frequency electrical
stimulation of the sciatic nerve resulting in contraction of the tibialis anterior and extensor
digitorum longus was commenced. I hypothesized that caffeine would attenuate anabolic
signaling through activation of AMPK and that LKB1 KO mice would not experience this
inhibition.
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MedicalLook.com
Figure 1.1: A Simplified Cross Section of a Skeletal Muscle.
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Figure 1.2: A Simplified Diagram Displaying Akt and AMPK as Regulators of the mTOR
Pathway.
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CHAPTER 2: Thesis
Introduction
Skeletal muscle has the ability to grow (hypertrophy) due to increased loading.
Hypertrophy in response to training is marked by an overall increase in the size of the skeletal
muscle fibers (myofibers) instead of amplification of the overall fiber number [Glass, 2010]. For
myofibers to undergo hypertrophy, the rate of protein synthesis must be greater than the rate of
protein degradation. Thus, there is a pivotal role for protein synthesis and other related pathways
that either promote the formation of proteins or impede their degradation.
The mammalian target of rapamycin complex 1 (mTORC1) and its associated pathway
has been shown to be a regulator of the increase in myofiber size with increased workload
[Bodine, 2001]. Activation of mTOR within mTORC1 increases protein synthesis by subsequent
phosphorylation of the serine/threonine kinase p70 S6 Kinase (S6K) which further targets and
phosphorylates ribosomal protein S6 and eukaryotic elongation factor 2 kinase [Baar, 1999].
mTORC1 has additional targets including eukaryotic translation initiation factor 4E-binding
protein 1 (4EBP1) and the downstream target eukaryotic elongation factor 2 (eEF2) just to name
a few [Kubica, 2005].
Tenotomy of the gastrocnemius muscle of the lower hind limb in the rat effectively
overloads (OVLD) the synergistic plantaris and soleus muscles and results in a 20 and 40%
increase in their weights respectively over a 14-day period [Goldberg, 1967]. Such hypertrophy
is accompanied by increased phosphorylation of anabolic signaling intermediates including
mTOR and S6 [Bodine, 2001; Thomson, 2006; Chale-Rush, 2009]. Additionally, highfrequency electrical stimulation (HFES) of the sciatic nerve has been shown to activate mTOR
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and result in skeletal muscle hypertrophy in the tibialis anterior (TA) and extensor digitorum
longus (EDL) muscles after a single bout [Baar 1999, Thomson, 2008].
The robust activation of the mTORC1 pathway can be accomplished by a number of
different methods including various nutrients such as amino acids or muscle growth factor
(MGFs) such as insulin-like growth factor-1 (IGF-1) [Rennie, 2003; Hornberger 2006]. One
regulator of mTORC1 is the molecule protein kinase B, also known as Akt. Akt is a signal
intermediate downstream of the insulin receptor and other growth receptors, which acts to
increase protein synthesis through mTORC1 during times of higher nutrient availability
[Suryawan, 2008].
An additional regulator is 5’ adenosine monophosphate-activated protein kinase
(AMPK). AMPK is activated by interaction with liver kinase B1 (LKB1) complexed with STErelated adaptor alpha (STRADα) and mouse protein 25 alpha (MO25α) [Hawley, 2003; Suter,
2006; Smith, 2011]. LKB1 is typically nuclear bound and must complex with STRADα and
MO25α before it is exported to the cytosol. As metabolic activity increases within a cell and the
ratio of AMP:ATP begins to increase, AMPK becomes activated [Shackelford, 2009]. This
activation leads to the inhibition of the mTORC1 pathway in skeletal muscles which prevents
anabolic signaling [Bolster, 2002; Thomson, 2008; Mounier, 2011].
Recent studies have shown that caffeine treatment at mM concentrations attenuates the
phosphorylation of Akt [Kolnes, 2010], and reduces the insulin-stimulated activity of mTOR in
incubated rat epitrochlearis muscle [Egawa, 2011]. Furthermore, multiple studies have shown an
increase in the phosphorylation of threonine 172 on AMPKa with caffeine treatment [Abbott,
2009; Lally, 2012]. This suggests that protein synthesis might be impacted by both regulatory
kinases. However, using caffeine concentrations of 3 – 10 mM are supraphysiological. Caffeine
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administration of 150 mg every eight hours resulted in steady state plasma concentrations of 1 –
14 uM [Birkett, 1991] while larger doses (3 – 6 mg/kg) result in 15 – 80 uM plasma
concentrations [Graham, 2001]. For reference, the average 8 oz cup of coffee usually contains
around 75 - 150 mg of caffeine depending upon the brand and method of brewing.
We sought to determine if physiologically relevant ingestion of caffeine could inhibit
anabolic signaling and ultimately attenuate skeletal muscle hypertrophy in vivo. We utilized
tenotomized OVLD rat and HFES of a skeletal muscle specific LKB1 knockout (skmLKB1-KO)
mouse models in these experiments. We hypothesized that OVLD induced hypertrophy of the
plantaris muscle within the rat will be diminished with caffeine treatment and that our
skmLKB1-KO mouse model will show that the effects of caffeine will be at least partially
dependent upon LKB1.
Materials and Methods
Rat OVLD Model
All proposed experimental procedures involving animals were approved by the
Institutional Animal Care and Use Committee of Brigham Young University.
Approximately 2 month old male Sprague Dawley rats were obtained from Charles River
Laboratories and housed in cages maintained in a 12-h light/dark, temperature controlled (2025°C) room with ad libitum food and water access. Rats were stratified based on weight into tap
water or tap water + caffeine (1 g/L) groups. Two d post treatment initiation, all rats underwent
unilateral tenotomy of the gastrocnemius and soleus muscles of the right hindlimb to induce
hypertrophy of the synergistic plantaris muscle. Rats were anesthetized using isoflurane (2-3%)
dissolved in oxygen and injected with the analgesic buprenorphine intraperitoneally at a
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concentration of 0.015 mg/ml and a dosage of 0.075 mg/kg BW using a 26 gauge needle.
Ophthalmic ointment was also applied to the eyes prior to surgery. Surgery was performed on a
water-circulating heat pad set to 37°C. The hindlimbs were shaved and scrubbed with
povodone-iodine solution. Using aseptic technique and materials, a 10-20 mm incision was
made along the posterior aspect of the lower hindlimb. The gastrocnemius tendon of the right
hindlimb was cut and sutured back onto the body of the muscle using 6-0 silk sutures to prevent
reattachment of the tendon. The contralateral hindlimb also underwent a similar incision, but
without the tenotomy. Both incisions were closed using sterile surgical staples and the rats were
returned to the animal quarters. One or two wks post surgery, as indicated, tissues were
harvested, quickly weighed, and then flash frozen in liquid nitrogen for protein analysis.
Mouse HFES Model
All mice were housed and bred in cages maintained in a 12-h light/dark temperature
sensitive (20-25 °C) room with no restriction to food and water availability. The skeletal muscle
specific LKB1 knockout (skmLKB1-KO) mouse was generated by crossing a transgenic mouse
having an LKB1 gene flanked by LoxP sites, provided by R. DePinho and N. Bardeesy (DanaFarber Cancer Institute in Boston, MA), with a Myf6-Cre transgenic mouse that heterozygously
expressed Cre recombinase specifically in skeletal muscle under the Myf6 (MRF4) promoter
[38]. The Myf6-Cre transgenic mouse was provided by M.R. Capecchi from the University of
Utah in Salt Lake City, Utah. Mice genotypes were tested via polymerase chain reaction using
primers specific for Cre and floxed LKB1 as described previously [Tanner, 2013]. Verification
by western blotting for LKB1 protein content was also used.
At approximately 12 wks of age, the above described mice were weighed and stratified
into groups according to weight. Mice received either an injection of saline or saline + caffeine
15

intraperitoneally via a 26 gauge needle at a concentration of 1 g/L and a dosage of 20 mg/kg
BW. Sixty min post injection; mice were anesthetized with isoflurane (2-3%) in supplemental
oxygen, injected with buprenorphine as an analgesic, and underwent a single bout of HFES.
Surgery was performed using sterile technique on a water-circulating heat pad set to 37°C. The
animals’ left upper hindlimb was shaved on the lateral side and scrubbed with povodone-iodine
solution. Ophthalmic ointment was applied to the eyes and the left sciatic nerve was exposed
through an incision along the lateral aspect of the upper hindlimb. Electrodes were placed on the
sciatic nerve and muscle contractions were stimulated in 3 sec durations with 10-12 V at 100 Hz.
Six sets of ten contractions (3 sec per contraction) were performed. Ten sec of rest were allowed
between contractions and 60 sec of rest between sets. Animals in the 0 h time point group had
their lower hindlimb muscles and blood removed immediately post HFES while the 3 and 8 hr
time points had the incision closed with wound clips. The 3 hr group remained under anesthesia
until harvest while the 8 hr group was allowed to awaken and return back to the animal quarters.
Tissues and blood were treated as described above.
Measurement of Protein Synthesis via Puromycin
Puromycin (Thermo Scientific, Waltham, MA, USA), was injected intraperitoneally into
1 wk treated rats and to mice in the 8 h group at a concentration of 5 mg/ml and a dosage of 22
mg/kg BW using a 26 gauge needle. At low concentrations, this antibiotic is able to mark newly
synthesized proteins and is thus a reliable indicator of protein synthesis [Goodman, 2011].
Puromycin was detected via western blotting as described below.
Tissue Homogenization
Tissues were ground using a pestle and mortar to sufficiently distribute the tissue. They
were then homogenized using a Bullet Blender from Next Advance Laboratories (Averill Park,
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NY, USA) in an appropriate volume/kg (1/19) of tissue solution of homogenization buffer (50
mM Tris-HCl, 250 mM Mannitol, 50 mM NaF, 5 mM Sodium Pyrophosphate, 1 mM EDTA, I
mM EGTA, 1% Triton X-100, 50 mM β-Glycerol Phosphate, pH 7.5, 1 M DTT, 1 M
Benzamidine, 5 ug/uL STI, 200 mM Na3VO4, and 200 mM PMSF). Homogenized tissues were
then sonicated using EpiShear Probe Sonicator (Active Motif, Carlsbad, CA, USA) at 30%
amplitude for 10 sec on ice after which a small aliquot was removed to determine the total
protein content of the muscle and frozen at -90°C. The remaining homogenate was vigorously
vortexed and spun at 21,000 g for 10 min to separate proteins from cellular components.
Supernatants were removed, flash frozen in liquid nitrogen, and stored at -90°C.
Protein Quantification and Western Blotting
Muscle homogenates were analyzed for protein concentration using BioTek® Synergy
HT multimode microplate reader and Bio-Rad DC Protein Assay Kit (Bio-Rad Laboratories,
Hercules, CA, USA) according to manufacturer’s protocols. Loading samples were then made in
appropriate amounts of homogenate and loading buffer. Samples then underwent western
blotting procedure on Criterion Precast Tris-HCl Bio-Rad gel. Gels underwent electrophoresis
before being transferred onto activated PVDF membranes. Concluding the transfer, membranes
were placed in Ponceaus-stain to ensure equal levels of protein per lane. PVDF membranes then
underwent standard immunodetection protocol for horseradish peroxidase conjugated antibodies.
The primary antibodies used were: pAMPKa (Cell Signaling 2535), AMPKa (Cell Signaling
2532), LKB1 (Millipore 07-694), pS6K (Cell Signaling 9206), S6K (Cell Signaling 2708),
p4EBP1 (Cell Signaling 2855), 4EBP1 (Cell Signaling 9644), peEF2 (Cell Signaling 2331),
eEF2 (Cell Signaling 2332), pAkt (Cell Signaling 4060), Akt (Cell Signaling 9272), pS6 (Cell
Signaling 4858), S6 (Cell Signaling 2217), Puromycin (Santa Cruz). Membranes were exposed
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to autoradiographic film and resulting band intensities were determined using AlphaEase FC
Software version 3.1.2 (Alpha Innotech Corporation, Santa Clara, California, USA).
Statistical Analysis
Figure composition and statistical analysis was performed using GraphPad Prism
software (Graphpad Software, Inc.). All data collected is expressed as mean ± standard error
(SE). Each group was compared using repeated measures analysis of variance, Fishers least
significant difference post-hoc analysis, or Student’s t-test where appropriate to identify
significant differences.
Results
Animal Parameters Following OVLD and Caffeine
The initial and final body weights along with the group size, body weight gain, heart and
retroperitoneal fat pad weight, and food consumed of all rats used in the OVLD experiments are
outlined in Table 2.1. Caffeine treatment resulted in decreased body weight gains and final
weights in 1 wk treated rats. However, weights began to normalize after two wks which showed
no difference between tap water and tap water + caffeine treatment. Heart weight remained
unchanged over the course of the experiment while caffeine treatment resulted in smaller
retroperitoneal fat pads in both 1 and 2 wk treated rats. Food consumption of standard chow for
both 1 and 2 wk treated rats is shown as total amount consumed for the duration of the particular
treatment period. Caffeine treatment resulted in decreased food consumption in both 1 and 2 wk
treated rats.
The hypertrophy of the plantaris was calculated as the percent increase in wet weight of
the OVLD vs. SHAM plantaris muscles (Figure 2.1A). Tap water treated rats resulted in
significant hypertrophy of the OVLD plantaris after 1 wk. Caffeine treatment attenuated this
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hypertrophy in 1 wk treated rats significantly. However, this diminishing effect was not seen in
the 2 wk treated rats where tap water and tap water + caffeine treated rats hypertrophied at
similar rates. Notably, OVLD tap water treated plantaris muscles did not show a significant
increase from 1 to 2 wks consistent with previous reports [Goldberg, 1967]. The total protein
content of plantaris muscles was calculated as mg of protein per plantaris muscle. Total protein
content data was consistent with the above stated plantaris hypertrophy data showing an increase
in protein accretion with OVLD after 1 wk (Figure 2.2A). This increase was diminished with the
addition of caffeine. However, after 2 wks of treatment, caffeine did not abate the increase in
total protein levels as tap water and tap water + caffeine showed significant amplification with
OVLD (Figure 2.2B).
The atrophy of the tenotomized gastrocnemius muscle was also calculated as percent
decrease in wet weight of the tenotomized vs. SHAM operated gastrocnemius (Figure 2.1B).
Tap water treated rats showed higher rates of gastrocnemius atrophy when compared to those
treated with caffeine after 1 wk. Nevertheless, this was absent after 2 wks of treatment which
showed similar rates of atrophy in tap water and tap water + caffeine treated rats.
Effect of OVLD and Caffeine on Regulators of Protein Synthesis
Western blotting of the plantaris muscle from 1 wk treated rats showed an increase in the
phosphorylation of Akt (pAkt) with OVLD which was attenuated with the addition of caffeine
(Figure 2.3A). After 2 wks of OVLD, pAkt was not upregulated in tap water or tap water +
caffeine treated rats (Figure 2.3B). The phosphorylation of AMPK (pAMPK) decreased in the 1
wk caffeine SHAM group when compared to the corresponding tap water treated group (Figure
2.3C). pAMPK was not upregulated after 1 wk of OVLD in tap water treated rats. However,
OVLD resulted in upregulation of pAMPK to tap water treated levels with caffeine treatment
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after 1 wk. pAMPK levels in 2 wk treated rats tended to increase with OVLD in both treatment
groups (Figure 2.3D). There were no changes in the total protein content for Akt or AMPK in
either 1 or 2 wk treated rats (data not shown).
Effect of OVLD and Caffeine on Markers of Protein Synthesis
Western blotting for markers of protein synthesis including S6K, S6, 4EBP1, and eEF2
was undertaken on the plantaris muscle from both 1 and 2 wk treated rats. The phosphorylation
of S6K (pS6K) increased in all OVLD muscle in both 1 and 2 wk rats with no differences
observed with caffeine treatment (Figure 2.4A). A similar result was observed in
phosphorylation of S6 (pS6) where again caffeine treatment had no impact (Figure 2.4B). The
phosphorylation of 4EBP1 (p4EBP1) tended to increase with OVLD although the effect was
only significant in tap water treated 1 wk rats (Figure 2.4C). The phosphorylation of eEF2
(peEF2) did not show an increase with OVLD in any treatment group although it tended to
increase in tap water and tap water + caffeine treated 1 wk rats (Figure 2.4D). There were no
changes in the total protein content for S6K, S6, 4EBP1, or eEF2 in any 1 or 2 wk treated rats
(data not shown). Puromycin levels increased with OVLD in 1 wk tap water treated rats and was
not impacted by caffeine treatment (Figure 2.4E).
Effect of HFES and Caffeine on Regulators of Protein Synthesis
Animal parameters for all mice used in the HFES experiments are shown in table 2.2.
Western blotting of the combined TA and EDL for regulators of protein synthesis, AMPK and
Akt, was undertaken in the 0, 3, and 8 h conditional (COND) or skmLKB1-KO mice. In the 0 h
group, pAkt did not change with HFES in saline treated muscles (Figure 2.5A). However, pAkt
increased at 0 h with HFES in skmLKB1-KO saline treated mice while those treated with
caffeine had no response to HFES. The 3 and 8 h mice showed little changes in pAkt although it
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is interesting to note a potent response in the 8 h skmLKB1-KO mice when compared to their
COND mice littermates (Figure 2.5B & C). There were no changes observed in the total protein
content of Akt in any of the 0, 3, or 8 h groups (Data not shown). pAMPK significantly
increased with HFES in 0 h COND mice; an event that was completely abolished in the
skmLKB1-KO mice as expected (Figure 2.5D). The 3 and 8 h groups showed unchanging levels
of pAMPK with HFES in either genotypes but the COND mice had pAMPK levels that were
higher than their skmLKB1-KO littermates (Figure 2.5E & F). In all time groups measured, the
total protein content of AMPK was significantly higher in the skmLKB1-KO mice when
compared to COND mice (data not shown).
Effect of HFES and Caffeine on Markers of Protein Synthesis
Western blotting of the combined TA and EDL for markers of protein synthesis including
S6K, S6, 4EBP1, and eEF2 was undertaken in the 0, 3, and 8 h COND or skmLKB1-KO mice.
pS6K increased with HFES at all time points which was only attenuated with caffeine in
skmLKB1-KO mice at 3 h (Figure 2.6A-C). Interestingly, the phosphorylation state of S6K
showed a main effect increase in the skmLKB1-KO mice for all time points, an observation also
seen in the total levels of S6K (data not shown). These results were also noticed in the S6K
target S6 where the phosphorylation increased with HFES and skmLKB1-KO (Figure 2.6D-F).
Total S6 protein content showed similar main effect increases with skmLKB1-KO (data not
shown). The phosphorylation levels of eEF2 were lower in muscles from skmLKB1-KO mice at
all time points and tended to decrease with HFES (Figures 2.6G-I). Total eEF2 protein content
showed similar main effect increases with skmLKB1-KO (data not shown). Additionally, our
KO mouse continued to show increased band shifting, indicative of increased phosphorylation, in
4EBP1along with HFES in 0, 3, and 8 h mice (Figure 2.6J-L). HFES resulted in increased band
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shifting of 4EBP1 in 0 h saline treated COND mice as well as both saline and saline + caffeine
treated 3 h COND mice. Puromycin increased with HFES after 8 h in COND saline treated mice
as well as with skmLKB1-KO, consistent with previous findings (Figure 2.7A).
Discussions
Caffeine is arguably the most consumed compound today and it is also routinely found in
those supplements that are intended to aide in skeletal muscle hypertrophy. Recent scientific
literature has suggested that caffeine could potentially have deleterious effects upon hypertrophy
essentially rendering the nutritional supplements they are commonly found in less effective
[Kolnes, 2010; Egawa, 2011]. However, to our knowledge, no studies to date have analyzed the
impact of caffeine treatment upon anabolic signaling and skeletal muscle hypertrophy in vivo.
Our findings indicate that caffeine at physiological levels does not induce sustained
abatement of anabolic signaling or skeletal muscle hypertrophy. Previous work in cell culture
showed that caffeine at 3 – 5 mM levels effectively attenuated the insulin induced increases in
pS6K and pAkt [Egawa, 2011]. Initial studies conducted by our group repeated these results in
L6 myotubes at concentrations as low as 0.625 mM but not lower (unpublished data). These
concentrations show that caffeine is effective, however, at dosage levels that are not
physiologically relevant and suggests that caffeine at physiological levels may not have any
effect. Experimentally safe caffeine concentrations in the blood are 40 – 80 uM, still about 10
times below the lowest dose that we could elicit a response with the LD50 in humans around 40
– 80 mM depending upon the individual [Graham, 2001]. The dosage used here results in
plasma levels of 20 – 50 uM, equivalent to consumption of 2 – 5 cups of coffee in humans
[Egawa, 2011].
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While caffeine did not attenuate anabolic signaling in our study, hypertrophy and total
protein content were diminished by caffeine in 1 wk treated rats. By two wks this effect was no
longer seen. This raises several interesting questions as to how caffeine is inhibiting the growth
of the plantaris after 1 wk but not after 2 wks of treatment. One possible explanation could be a
tolerance effect that rats gained towards constant caffeine administration after 1 wk due to a
potential upregulation of adenosine receptors, consistent with previous findings [Fredholm,
1982; Zhang, 1990]. A sec explanation is that caffeine is a diuretic and could be dehydrating the
muscles after 1 wk impairing the rate of protein synthesis [Maughan, 2003]. 1 wk treated rats
did tend to drink less water although the difference was not significant (p=0.13, data not shown)
and was nearly equally after 2 wks. This could explain the “lighter” plantaris muscles being
shown as decreased hypertrophy with caffeine treatment. It is also curious to note the difference
in hypertrophy in 1 and 2 wk treated rats. Tap water only treated rats did not show significant
growth differences from 1 to 2 wks of OVLD implying a ceiling effect for this model, consistent
with previous findings [Goldberg, 1967]. Caffeine treated rats were able to grow at an increased
rate and essentially catch up to their tap water treated counterparts again perhaps suggesting a
tolerance to caffeine was obtained. Decreased food consumption does not adequately explain the
diminished plantaris hypertrophy or total protein levels in 1 wk treated animals as food
consumption was also lower in 2 wk treated rats. Additionally, the argument cannot be made
that if food consumption was depressed after 1 wk, it would stay lower even after 2 wks. This is
because the food consumption difference between treatment groups in 1 wk treated rats was less
than the difference after 2 wks suggesting caffeine sustained its ability to impact eating habits.
We also observed in caffeine treated rats after 1 wk of OVLD a larger gastrocnemius
within the tenotomized limb when compared to their tap water only counterparts. This suggests

23

caffeine resulted in a decrease in the rate of skeletal muscle atrophy. Atrophy of the tenotomized
gastrocnemius is an expected result due to decreased load [Goldspink 1983]. The OVLD
experiment and tenotomy surgery is taxing upon the hindlimb of the animal resulting in high
levels of local inflammation, swelling, and scarring during the first wk but which typically
subsides by 2 wks. Our observation would be consistent with the idea that higher levels of
inflammatory cytokines contribute to skeletal muscle atrophy and that caffeine suppress the
inflammatory response as shown by others [Miwa, 2012; Wüst, 2007; Barcelos, 2014]. The
larger caffeine treated tenotomized gastrocnemius was not observed in 2 wk treated rats
suggesting that the major inflammatory events have subsided by that time or that a tolerance to
caffeine had been obtained. It would be interesting to analyze the impact of caffeine upon such
inflammatory markers within the 1 wk treated animals.
Additionally, in both 1 and 2 wk treated rats, the size of the retroperitoneal fat pad was
reduced. This suggests that caffeine has the ability to mobilizing fat stores. However, both 1
and 2 wk treated rats consumed less chow which could explain the diminished fat pads, a result
that may or may not be consistent with previous findings as current research is highly conflicting
[Sugiura, 2012; Gavrieli, 2013; Jessen, 2005; Carter, 2012]. Sugiura et al utilized 10 wk old
female mice and a similar caffeine concentration which showed no change in total food intake
after 4 wks but caffeine treated mice did tend to have lower body weights. However, studies by
Gavrieli et al, Jessen et al, and Carter et al in humans all suggest that caffeine has the ability to
decrease appetite. Further studies are warranted concerning this matter. Pair feeding of the rats
would have been undertaken had previous literature in rats suggested differing consumption
rates.
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Rather unexpectedly, we also observed that by knocking out the gene that encodes for
LKB1, an upstream regulator of AMPK, markers of anabolic signaling were enhanced. We
initially hypothesized that caffeine would down regulate mTOR activity through increased
phosphorylation of AMPK. Thus, we utilized a skmLKB1-KO mouse in the sec experiment to
help elucidate the mechanism with which caffeine could potentially impair anabolic signaling.
However, caffeine did not negatively impact anabolic signaling which was further proven by our
HFES results. Nevertheless, we did unexpectedly observe differences between genotypes where
the total protein and phosphorylation states of nearly all markers of anabolic signaling measured
including S6K, S6, 4EBP1, eEF2, and Puromycin were elevated in skmLKB1-KO muscles.
Because total protein levels of targets measured were also higher in the 0 h group, it can be
reasoned that skmLKB1-KO mice chronically have modest, but statistically heightened levels of
anabolic signaling. This result is consistent with some [Thomson, 2008; Ikeda, 2009; Jessen,
2010] but not all published literature [McGee, 2008]. Thomson et al, Ikeda et al, and Jessen et al
utilized LKB1-KO mice that included cardiac muscle with all groups indicated a heighted
anabolic signaling response. However, McGee et al utilized a skeletal muscle specific LKB1KO mouse which reported no differences in muscle size but a trend for an increase in anabolic
signaling after 7 d of OVLD. McGee et al did not report the age of mice used and only reports a
sample size of 3 which could explain why no significant differences are seen. It is also worth
noting that multiple studies utilizing various cancer models indicate heightened mTOR signaling
in response to aberrant LKB1 activity. While it is tempting to say all of this is caused by
diminished AMPK activity, LKB1 has a variety of other targets within skeletal muscle which
could also play a role in anabolic signaling. It would be interesting to determine the impact that
other LKB1 targets have upon anabolic signaling within skeletal muscle.
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We further observed that the marked upregulation of anabolic signaling occurs
independent of Akt phosphorylation in response to HFES. This suggests that contraction or
some other mechanism is activating mTOR targets. We also observed that this upregulation is
evident immediately after HFES but continues to amplify at least up to 8 h later. Both
observations are consistent with previous findings [Sherwood, 1999; Parkington, 2003;
Thomson, 2008]. Furthermore, in our skmLKB1-KO mice, there was an increase in Akt
phosphorylation 8 h after stimulation suggesting an ability of LKB1 to regulate Akt, in harmony
with published data [Koh, 2006]. It is interesting to note that this increase is in both stimulated
and unstimulated muscles at 8 h but is not observed 0 or 3 h post stimulation perhaps because
mice were kept under anesthesia for their respective durations and did not feed.
In conclusion, we observed that caffeine at physiological concentrations did not induce a
sustained impact upon anabolic signaling or skeletal muscle hypertrophy after OVLD or HFES
in rats and mice respectively. In addition, deletion of LKB1 within skeletal muscle was enough
to result in small, but sustained increases in markers of protein synthesis. Further work should
be commenced to determine if these effects are through interaction with AMPK or another of the
LKB1 family members.
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1 Week Water
(n=9)

1 Week Caffeine
(n=9)

2 Week Water
(n=10)

2 Week Caffeine
(n=10)

Initial BW (g)

199.9 ± 4.6

197.8 ± 4.2

202.8 ± 3.2

205.1 ± 4.0

Final BW (g)

273.8 ± 3.9

250.1 ± 5.5

305.5 ± 8.0

295.1 ± 8.2

Body Weight Gain (%)

37 ± 1.7

26 ± 2.5

§

51 ± 3.8

44 ± 3.7

Food Consumed (g)

195 ± 8

167 ± 8

#

373 ± 9

Heart Weight (% of BW)

0.317 ± 0.004

Adipose Weight (% of BW)

1.89 ± 0.17

§

0.328 ± 0.014
1.49 ± 0.08

#

0.300 ± 0.005
2.80 ± 0.28

335 ± 14

#

0.297 ± 0.006
1.76 ± 0.17

§

Table 2.1: Animal Measurements in 1 and 2 Wk Treated Rats. The initial and final body weight
(grams) along with the group size (n), body weight gain (% of initial BW), food consumed
(grams), heart weight (% of BW), and retroperitoneal fat pad weight (% of BW) of rats used in
the OVLD experiments. All values are mean ± SE. # Significantly different from corresponding
water treated animal (P < 0.05). § Significantly different from corresponding water treated
animal (P < 0.01).
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0 Hour
(n = 8)
3 Hour
(n = 6-10)
8 Hour
(n = 7-9)

Cond Saline

Cond Caffeine

KO Saline

KO Caffeine

Weight (g)

23.6 ± 0.8

24.0 ± 0.5

23.4 ± 0.7

23.2 ± 0.8

Age (days)

102 ± 2

104 ± 2

102 ± 3

98 ± 2

Weight (g)

23.2 ± 0.6

22.8 ± 0.9

21.6 ± 1.4

23.1 ± 0.8

Age (days)

98 ± 4

96 ± 5

89 ± 2

95 ± 3

Weight (g)

24.1 ± 1.1

24.1 ± 1.0

22.7 ± 1.8

22.7 ± 0.6

Age (days)

96 ± 2

97 ± 2

92 ± 3

96 ± 3

Table 2.2: Animal Group Parameters in the 0, 3, and 8 H Treated Mice. The age, weights, and
group size of all mice used in the HFES experiments. All values are mean ± SE.
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A
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Week 1
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16%

Gastrocnemius Atrophy

Plantaris Hypertrophy

18%
14%
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8%
6%
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Week 1
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Week 2

§

Water
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Figure 2.1: Plantaris Hypertrophy and Gasctrocnemius Atrophy in 1 and 2 Wk Treated
OVLD Rats. Plantaris hypertrophy for both 1 and 2 wk treated rats (A). Gastrocnemius atrophy
for both 1 and 2 wk treated rats (B). Calculated as percent hypertrophy or atrophy from the
SHAM operated plantaris using the “wet” weights of the OVLD and SHAM plantaris muscles.
All values are mean ± SE (n=9-10). § Significantly different from corresponding water treated
muscle (P < 0.01).
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Figure 2.2: Total Protein Content of the Plantaris in 1 and 2 Wk Treated OVLD Rats. Displayed
as mg protein / plantaris. All values are mean ± SE (n=7-10). # Significantly different from
corresponding SHAM muscle (P < 0.05).
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Figure 2.3: Western Blots of pAkt and pAMPK in 1 and 2 Wk Treated OVLD Rats.
Phosphorylation states of Akt at Ser 473 and AMPK Thr 172 (A-D). Representative images
from immunoblots (E). All values are mean ± SE (n=8-10). # Significantly different from
corresponding SHAM muscle (P < 0.05). Θ Significantly different from corresponding water
treated muscle (P < 0.05). ‡ Significant main effect vs. water treated muscles (P < 0.05). P = 0.09
from corresponding water treated muscles.
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Figure 2.4: Western Blots of mTOR Targets S6K, S6, eEF2, and 4EBP1 along with
Puromycin in 1 and 2 Wk Treated OVLD Rats. Phosphorylation states of S6K at Thr 389, S6 at
Ser 235/236, 4EBP1 at Thr 37/46, and eEF2 at Thr 56 (A-D). Representative images from
immunoblots (F). Puromycin injected into 1 wk rats was detected via western blotting of the
plantaris muscle, showed main effect OVLD > SHAM (p=0.02) (E). Representative images
from immunoblot (G). All values are mean ± SE (n=5-10). # Significantly different from
corresponding SHAM or water treated muscle (P < 0.05). § Significantly different from
corresponding SHAM muscle (P < 0.01). ∞ Significantly different from corresponding SHAM
muscle (p<0.001). P = 0.09 from corresponding SHAM treated muscles.
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Figure 2.5: Western Blots of pAkt and pAMPK in 0, 3, and 8 H HFES Mice. Western blots are
of the TA/EDL for time groups and are assessing the phosphorylation states of Akt at Ser 473
(A-C) and AMPK Thr 172 (D-F). Representative images from immunoblots (G). All values are
mean ± SE (n=6-10). # Significantly different from corresponding Rest muscle (P < 0.05). §
Significantly different from corresponding Rest muscle (P < 0.01). Θ Significant difference main
effect from COND muscles (P < 0.05).
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Figure 2.6: Western Blots of mTOR Targets S6K, S6, eEF2, and 4EBP1 in 0, 3, and 8
H HFES Mice. Phosphorylation states of S6K at Thr 389, S6 at Ser 235/236 and eEF2 at Thr 56
with 4EBP1 represented by phosphorylated band shifting (A-L). All values are mean ± SE (n=610). # Significantly different from corresponding resting muscle (P < 0.05). § Significantly
different from corresponding resting muscle (P < 0.01). ∞ Significantly different from
corresponding resting muscle (P < 0.001). ‡ Significantly different from corresponding saline
treated muscle (P < 0.05). Θ Significant difference main effect from COND muscles (P < 0.05).
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